- Home
- VRAX vs ADIL Comparison
VRAX vs ADIL Comparison
Compare VRAX & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- ADIL
- Stock Information
- Founded
- VRAX 2013
- ADIL 2010
- Country
- VRAX United Kingdom
- ADIL United States
- Employees
- VRAX N/A
- ADIL N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- VRAX Health Care
- ADIL Health Care
- Exchange
- VRAX Nasdaq
- ADIL Nasdaq
- Market Cap
- VRAX 4.7M
- ADIL 3.9M
- IPO Year
- VRAX 2022
- ADIL 2018
- Fundamental
- Price
- VRAX $0.79
- ADIL $0.31
- Analyst Decision
- VRAX Strong Buy
- ADIL Strong Buy
- Analyst Count
- VRAX 1
- ADIL 1
- Target Price
- VRAX $3.00
- ADIL $8.00
- AVG Volume (30 Days)
- VRAX 38.7K
- ADIL 22.4M
- Earning Date
- VRAX 02-05-2025
- ADIL 08-12-2025
- Dividend Yield
- VRAX N/A
- ADIL N/A
- EPS Growth
- VRAX N/A
- ADIL N/A
- EPS
- VRAX N/A
- ADIL N/A
- Revenue
- VRAX $84,872.00
- ADIL N/A
- Revenue This Year
- VRAX $5,169.18
- ADIL N/A
- Revenue Next Year
- VRAX $66.97
- ADIL N/A
- P/E Ratio
- VRAX N/A
- ADIL N/A
- Revenue Growth
- VRAX 7.03
- ADIL N/A
- 52 Week Low
- VRAX $0.74
- ADIL $0.22
- 52 Week High
- VRAX $9.00
- ADIL $3.00
- Technical
- Relative Strength Index (RSI)
- VRAX 31.75
- ADIL 50.21
- Support Level
- VRAX $0.75
- ADIL $0.22
- Resistance Level
- VRAX $0.85
- ADIL $0.27
- Average True Range (ATR)
- VRAX 0.07
- ADIL 0.08
- MACD
- VRAX -0.01
- ADIL -0.01
- Stochastic Oscillator
- VRAX 6.57
- ADIL 53.15
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.